Back to Insights

Ori Spotlight #30 – Vered Caplan, Orgenesis.

Episode 30

We’re joined by Vered Caplan, CEO of Orgenesis, as she shares her insights into the cell and gene therapy sector.

With a background in engineering and business, Vered found her passion in the cell and gene therapy industry. She founded Orgenesis with a mission to bring innovative therapies to patients, by leveraging cutting-edge science to create a more efficient, scalable, and affordable pathway to patients.

In this episode, Vered discusses:

  • The need for greater adoption of technology to overcome manufacturing challenges of advanced therapies
  • Why digital is the key to tailoring manufacturing processes to the individual needs of patients
  • How industry partnerships support the scalability of therapy products

Further information


Share this page